Physician profile
Brandon Smith
NPI 1255947255
$2,627.52
in general payments reported to CMS, 2019-2025
25 companies · $673 in 2025
The $673 reported for 2025 was more than what 79% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $71.63 · 2022: $710 · 2023: $576 · 2024: $597 · 2025: $673.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,812 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $34.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,812.36 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $34.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $890.69 | 2021-2025 | |
| Lilly USA, LLC | $299.12 | 2022-2025 | Mounjaro, Jardiance, Zepbound |
| Novo Nordisk INC | $292.88 | 2022-2025 | Rybelsus, Ozempic, Wegovy |
| Amgen INC. | $203.37 | 2022-2025 | Evenity, Prolia |
| Astellas Pharma US INC | $167.87 | 2023-2025 | Veozah |
| Sanofi Pasteur INC. | $92.14 | 2022-2025 | |
| Exact Sciences Corporation | $79.04 | 2023-2025 | Cologuard Collection Kit |
| Janssen Pharmaceuticals, INC | $59.66 | 2023-2025 | Spravato |
| Biohaven Pharmaceutical Holding Company LTD. | $57.14 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $55.16 | 2022-2024 | Farxiga |
| Pfizer INC. | $49.64 | 2024-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $43.32 | 2021-2022 | |
| Phathom Pharmaceuticals, INC. | $41.36 | 2024-2025 | Voquezna |
| Viatris Specialty LLC | $38.79 | 2025 | Yupelri |
| Becton, Dickinson and Company | $34.00 | 2025 | Introducer Needle |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $31.99 | 2022 | |
| Vanda Pharmaceuticals INC. | $28.15 | 2024 | Fanapt |
| Tandem Diabetes Care, INC. | $26.01 | 2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Glaxosmithkline, LLC. | $24.93 | 2022-2023 | Shingrix, Bexsero, Arexvy |
| Xeris Pharmaceuticals, INC. | $22.24 | 2025 | Recorlev |
| Merck Sharp & Dohme LLC | $20.68 | 2025 | Verquvo |
| Tris Pharma INC | $20.22 | 2023 | Dyanavel Xr |
| Medtronic, INC. | $17.68 | 2023 | Minimed 770g |
| Corcept Therapeutics | $17.29 | 2024 | Korlym |
| Mayne Pharma Commercial LLC | $14.15 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandon Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.